{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:47:52Z","timestamp":1789627672223,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"R21","award":["CA155674"],"award-info":[{"award-number":["CA155674"]}]},{"name":"Cancer Center Support","award":["P30 CA91842"],"award-info":[{"award-number":["P30 CA91842"]}]},{"name":"NRG Oncology Operations","award":["U10 CA180868"],"award-info":[{"award-number":["U10 CA180868"]}]},{"name":"NRG SDMC","award":["U10 CA180822"],"award-info":[{"award-number":["U10 CA180822"]}]},{"name":"Gynecologic Oncology Group (GOG) Administrative Office"},{"name":"GOG Tissue Bank","award":["CA27469"],"award-info":[{"award-number":["CA27469"]}]},{"name":"GOG Statistical and Data Center","award":["CA37517"],"award-info":[{"award-number":["CA37517"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ygyno.2015.06.038","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T07:44:24Z","timestamp":1436082264000},"page":"614-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology\/Gynecologic Oncology Group study"],"prefix":"10.1016","volume":"138","clinical-trial-number":[{"clinical-trial-number":"nct00340808","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Israel","family":"Zighelboim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamshad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Lankes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9225-6913","authenticated-orcid":false,"given":"Floor","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-1581","authenticated-orcid":false,"given":"David","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katina","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Behbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel G.","family":"Ghebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilsa C.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Goodfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.06.038_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/whe.14.13","article-title":"Update on prognostic markers for endometrial cancer","volume":"10","author":"Binder","year":"2014","journal-title":"Women Health"},{"key":"10.1016\/j.ygyno.2015.06.038_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2015.06.038_bb0020","first-page":"5100","article-title":"Genetic instability of microsatellites in endometrial carcinoma","volume":"53","author":"Risinger","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0025","first-page":"1671","article-title":"Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma","volume":"148","author":"Caduff","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0030","first-page":"462","article-title":"Causes and consequences of microsatellite instability in endometrial carcinoma","volume":"59","author":"Gurin","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0035","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1073\/pnas.1030231100","article-title":"Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers","volume":"100","author":"Goodfellow","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0040","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.2006.08.2107","article-title":"Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type","volume":"25","author":"Zighelboim","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0045","first-page":"4095","article-title":"Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability","volume":"62","author":"Vassileva","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0050","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1158\/0008-5472.CAN-05-1019","article-title":"Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance","volume":"65","author":"Lewis","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0055","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M106287200","article-title":"S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function","volume":"277","author":"Cliby","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0060","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2008.19.9802","article-title":"ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes","volume":"27","author":"Zighelboim","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/gcc.20782","article-title":"A GOG210 ACGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome","volume":"49","author":"Morrison","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.ygyno.2015.06.038_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2013.02.023","article-title":"Etiologic heterogeneity in endometrial cancer: evidence from a gynecologic oncology group trial","volume":"129","author":"Brinton","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0075","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0080","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1073\/pnas.93.7.2850","article-title":"cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein","volume":"93","author":"Cimprich","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.13.2.152","article-title":"A role for ATR in the DNA damage induced phosphorylation of p53","volume":"13","author":"Tibbetts","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0090","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1158\/0008-5472.CAN-13-3229","article-title":"ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency","volume":"74","author":"Mohni","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctrv.2013.03.002","article-title":"Targeting ATR in DNA damage response and cancer therapeutics","volume":"40","author":"Fokas","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ygyno.2015.06.038_bb0100","doi-asserted-by":"crossref","first-page":"e57098","DOI":"10.1371\/journal.pone.0057098","article-title":"Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells","volume":"8","author":"Sultana","year":"2013","journal-title":"PLoS One"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T21:21:33Z","timestamp":1717968093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815300597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0090825815300597"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology\/Gynecologic Oncology Group study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}